Regencell Bioscience Valuation
| RGC Stock | USD 5.22 0.48 10.13% |
At this time, the company appears to be overvalued. Regencell Bioscience holds a recent Real Value of $4.83 per share. The prevailing price of the company is $5.22. Our model determines the value of Regencell Bioscience from analyzing the company fundamentals such as Shares Owned By Institutions of 0.12 %, shares outstanding of 13.01 M, and Return On Equity of -0.42 as well as examining its technical indicators and probability of bankruptcy. In general, most investors support purchasing undervalued entities and exiting overvalued entities since, at some point, asset prices and their ongoing real values will merge together. Key fundamental drivers impacting Regencell Bioscience's valuation include:
Price Book 4.1212 | Enterprise Value 56.8 M | Enterprise Value Ebitda (6.99) |
Overvalued
Today
Please note that Regencell Bioscience's price fluctuation is very risky at this time. Calculation of the real value of Regencell Bioscience is based on 3 months time horizon. Increasing Regencell Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Regencell Bioscience Holdings is useful when determining the fair value of the Regencell stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Regencell Bioscience. Since Regencell Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Regencell Stock. However, Regencell Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.22 | Real 4.83 | Hype 5.34 | Naive 4.95 |
The real value of Regencell Stock, also known as its intrinsic value, is the underlying worth of Regencell Bioscience Company, which is reflected in its stock price. It is based on Regencell Bioscience's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Regencell Bioscience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Regencell Bioscience's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Regencell Bioscience Holdings helps investors to forecast how Regencell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Regencell Bioscience more accurately as focusing exclusively on Regencell Bioscience's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Regencell Bioscience's intrinsic value based on its ongoing forecasts of Regencell Bioscience's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Regencell Bioscience's closest peers. When choosing an evaluation method for Regencell Bioscience, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Regencell Bioscience Investments |
|
Regencell Valuation Trend
Knowing Regencell Bioscience's actual value is paramount for traders to make sound investment determinations. Regencell Bioscience's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Regencell Bioscience's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Regencell Bioscience's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Regencell Market Cap
Regencell Bioscience Holdings is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 6.99 Billion. Regencell Bioscience maintains roughly 67.93 Million in market capitalization contributing less than 1% to equities under Health Care industry.Regencell Bioscience Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Regencell Bioscience's current stock value. Our valuation model uses many indicators to compare Regencell Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Regencell Bioscience competition to find correlations between indicators driving Regencell Bioscience's intrinsic value. More Info.Regencell Bioscience Holdings is rated fourth in price to earning category among related companies. It is rated third in price to book category among related companies fabricating about 0.16 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Regencell Bioscience Holdings is roughly 6.36 . As of April 19, 2024, Price To Book Ratio is expected to decline to -2.01. Comparative valuation analysis is a catch-all model that can be used if you cannot value Regencell Bioscience by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Regencell Bioscience's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Regencell Bioscience's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Regencell Bioscience's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Regencell Bioscience and how it compares across the competition.
About Regencell Bioscience Valuation
The stock valuation mechanism determines the current worth of Regencell Bioscience Holdings on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Regencell Bioscience Holdings. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Regencell Bioscience based exclusively on its fundamental and basic technical indicators. By analyzing Regencell Bioscience's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Regencell Bioscience's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Regencell Bioscience. We calculate exposure to Regencell Bioscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Regencell Bioscience's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -692.7 K | -658.1 K | |
| Pretax Profit Margin | 0.08 | 0.09 | |
| Operating Profit Margin | 0.1 | 0.12 | |
| Net Profit Margin | 0.04 | 0.05 | |
| Gross Profit Margin | 1.11 | 0.98 |
8 Steps to conduct Regencell Bioscience's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Regencell Bioscience's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Regencell Bioscience's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Regencell Bioscience's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Regencell Bioscience's revenue streams: Identify Regencell Bioscience's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Regencell Bioscience's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Regencell Bioscience's growth potential: Evaluate Regencell Bioscience's management, business model, and growth potential.
- Determine Regencell Bioscience's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Regencell Bioscience's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Regencell Bioscience Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Regencell Bioscience does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 13 M |
Regencell Bioscience Current Valuation Indicators
Valuation refers to the process of determining the present value of Regencell Bioscience Holdings and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Regencell we look at many different elements of the entity such as Regencell's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Regencell Bioscience's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Regencell Bioscience's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Regencell Bioscience, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Regencell Bioscience's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Regencell Bioscience's worth.When determining whether Regencell Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regencell Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regencell Bioscience Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regencell Bioscience Holdings Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regencell Bioscience Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Regencell Bioscience information on this page should be used as a complementary analysis to other Regencell Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Regencell Stock analysis
When running Regencell Bioscience's price analysis, check to measure Regencell Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regencell Bioscience is operating at the current time. Most of Regencell Bioscience's value examination focuses on studying past and present price action to predict the probability of Regencell Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regencell Bioscience's price. Additionally, you may evaluate how the addition of Regencell Bioscience to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Regencell Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regencell Bioscience. If investors know Regencell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regencell Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.45) | Return On Assets (0.26) | Return On Equity (0.42) |
The market value of Regencell Bioscience is measured differently than its book value, which is the value of Regencell that is recorded on the company's balance sheet. Investors also form their own opinion of Regencell Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Regencell Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regencell Bioscience's market value can be influenced by many factors that don't directly affect Regencell Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regencell Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Regencell Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regencell Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.